Last ¥1,858 JPY
Change Today +3.00 / 0.16%
Volume 1.9M
4568 On Other Exchanges
Symbol
Exchange
Tokyo
OTC US
OTC US
Frankfurt
As of 2:00 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kaoru Shimada

Former External Auditor, Daiichi Sankyo Company, Limited
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

80--

Background*

Mr. Kaoru Shimada served as Director of Microbiology, Tokyo Welfare Institute Hospital Since April 1972. Mr. Shimada served as Faculty of Medicine, the University of Tokyo, Department of Internal Medicine, in April 1960. Starting in August 1984, Mr. Shimada was a Professor for Infectious Diseases, Institute of Medical Science, the University of Tokyo. since April 1991, Mr. Shimada served as Director of the Research Hospital, The Institute of Medical Science, the University ...

Read Full Background

Corporate Headquarters*

3-5-1, Nihonbashi-honcho
Tokyo, -- 103-8426

Japan

Phone: 81 3 6225 1111
Fax: --

Board Members Memberships*

2005-N/A
Former External Auditor

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4568:JP ¥1,858.00 JPY +3.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jon P. Stonehouse Chief Executive Officer, President and Executive Director
BioCryst Pharmaceuticals, Inc.
$475.7K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$1.1M
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
Marc M.P. de Garidel Chairman, Chief Executive Officer and Member of Strategic Committee
Ipsen S.A.
€1.4M
Alexandre Mérieux Chief Executive Officer, Director and Member of Strategy Committee
bioMérieux SA
€544.9K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAIICHI SANKYO CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.